European Union
EMA and FDA establish common principles for the use of AI in medicine development
January 19, 2026
Don’t miss our content
SubscribeOn January 14, 2026, the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) jointly agreed on the ten guiding principles of good artificial intelligence (AI) practice in medicine development.
These principles provide broad guidance for the use of AI across all phases of the medicine lifecycle, from research and clinical trials to manufacturing and market entry.
The European Union (EU) is also working on additional AI guidelines.
For more information, please contact our specialists through the Knowledge and Innovation Area.
January 19, 2026
Don’t miss our content
Subscribe